An active prescription of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in diabetic patients undergoing surgery is linked to lower risks of 30-day readmission, postoperative wound dehiscence, and hematoma, according to a recent study. Out of 74,425 surgical procedures analyzed, the GLP-1 RA group demonstrated significant reductions compared to non-users. No differences were observed in infection or bleeding rates, suggesting these medications could enhance recovery outcomes in surgical patients with diabetes.
Journal Article by Aschen SZ, Zhang A (…) Spector JA et 4 al. in Ann Surg
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.